Malignant Pleural Mesothelioma (MPM)
7 clinical trials · Condition
◉ Watch Malignant Pleural Mesothelioma (MPM)
| Record | Firm | Date |
|---|---|---|
| Oral TEAD Inhibitor Targeting the Hippo Pathway in Subjects with Advanced Solid Tumors (NCT05228015) | Ikena Oncology | 2022-01-07 |
| A Study of NX-1607 in Adults With Advanced Malignancies (NCT05107674) | Nurix Therapeutics, Inc. | 2021-09-29 |
| Mesothelin-targeted CAR T-cell Therapy in Patients With Mesothelioma (NCT04577326) | Memorial Sloan Kettering Cancer Center | 2020-09-30 |
| A Phase Ib Trial of a Maintenance Multipeptide Vaccine (S-588210) in Patients With Unresectable Malignant Pleural Mesothelioma Without Progression After First-Line Chemotherapy (NCT02661659) | University of Chicago | 2016-06-12 |
| Metronomic Chemotherapy Based on Adaptative Bio-mathematical Model of Oral Vinorelbine in Patients With NSCLC or MPM (NCT02555007) | Assistance Publique Hopitaux De Marseille | 2015-08-26 |
Track Malignant Pleural Mesothelioma (MPM) automatically
Every clearance here is in the API, with alerts when new ones post.